Hypertension Deaths From Excessive Alcohol Use Are Increasing
By Elana Gotkine HealthDay Reporter
THURSDAY, July 3, 2025 -- The estimated mean annual number of hypertension deaths from excessive alcohol use was higher in 2020-2021 than in 2016-2017, with a higher increase among women than men, according to a study published in the July issue of the American Journal of Preventive Medicine.
Gregory Leung, Ph.D., from the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues estimated the proportion of hypertension deaths caused by excessive drinking among U.S. adults aged 20 years and older. Mean annual total hypertension deaths were calculated during 2016-2017 and 2020-2021, and the CDC Alcohol-Related Disease Impact tool was used to estimate mean annual hypertension deaths from excessive alcohol use.
The researchers found that among U.S. adults, the mean annual number of hypertension deaths was 41.5 percent higher during 2020-2021 than 2016-2017. During 2020-2021, the estimated mean annual number of hypertension deaths from excessive alcohol use was 51.6 percent higher than in 2016-2017 (55.7 and 45.1 percent higher among women and men, respectively). More than 60 percent of hypertension deaths caused by excess drinking were among women (61.2 and 62.8 percent in 2016-2017 and 2020-2021, respectively). Among women, there was an increase in the proportion of hypertension deaths attributable to excessive alcohol use, from 18.9 percent in 2016-2017 to 21.2 percent in 2020-2021; among men, the proportion remained around 13 percent.
"To reduce hypertension caused by excessive drinking, jurisdictions can create environments that support people in drinking less by implementing proven alcohol policies (e.g., regulating alcohol outlet density, increasing alcohol taxes)," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2025
Read this next
GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension
MONDAY, July 21, 2025 -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved...
ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
FRIDAY, July 18, 2025 -- All individuals with hypertension should be screened for primary aldosteronism (PA), according to a clinical practice guideline issued by the Endocrine...
Delays in HTN Diagnosis Linked to Delays in Medication Prescribing
THURSDAY, July 17, 2025 -- Delays in diagnosis of hypertension are common and associated with delays in treatment initiation, according to a study published online July 14 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.